tirzepatide and kidneys (Zepbound) showed improved kidney function in obese patients with both chronic kidney disease #heartfailure with preserved ejection fraction, highlighting its potential to address this high-risk patient population. Read more: https tirzepatide ckd trial sydney 🧬

Dr Jarred Younger, a prominent researcher in neuroinflammation and chronic pain, has publicly stated that semaglutide does reduce chronic pain via these three pathways, but also acknowledged that all the semaglutide and microglia studies I know of are in animal models theres still another step that needs to be taken. That caveat matters enormously, and its one well come back to

Use of palpation imaging in diagnosis of breast diseases: A way to improve the detection rate

A.SaffordM.KnowlerW

Association of Ang-(17) and des-Arg9BK as new biomarkers of obesity and cardiometabolic risk factors in adolescents

What about patients who are using non insulin self injectable drugs like Ozempic or Mounjaro and the diagnosis is Obesity/Weight loss